SEC Form SC 13G/A filed by Corvus Pharmaceuticals Inc. (Amendment)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

__________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

* Samlyn Capital, LLC (“Samlyn Capital”) is deemed to beneficially own warrants of the issuer (“Warrants”) that are directly owned by certain of Samlyn Capital’s investment advisory clients (such clients, the “Samlyn Clients”). The Warrants, each of which converts into shares of Common Stock on a 1 to 1 basis, are subject to a blocker provision that prevents each Samlyn Client from exercising the Warrants if it or any of its affiliates, including Samlyn Capital, would be more than a 9.99% beneficial owner of the issuer’s outstanding Common Stock following such exercise (the “Blocker Provision”). Accordingly, the number of shares of Common Stock and the percentage of the issuer’s outstanding Common Stock deemed beneficially owned by Samlyn Capital have been adjusted to account for: (i) the maximum amount of Warrants that the Samlyn Clients can collectively exercise, giving effect to the Blocker Provision; and (ii) the additional shares of Common Stock that would be issued by the issuer to the Samlyn Clients in connection with full exercise of the Warrants by the Samlyn Clients, giving effect to the Blocker Provision.

* Samlyn, LP is deemed to beneficially own warrants of the issuer (“Warrants”) that are directly owned by certain of Samlyn Capital, LLC’s (“Samlyn Capital”) investment advisory clients (such clients, the “Samlyn Clients”). The Warrants, each of which converts into shares of Common Stock on a 1 to 1 basis, are subject to a blocker provision that prevents each Samlyn Client from exercising the Warrants if it or any of its affiliates, including Samlyn, LP, would be more than a 9.99% beneficial owner of the issuer’s outstanding Common Stock following such exercise (the “Blocker Provision”). Accordingly, the number of shares of Common Stock and the percentage of the issuer’s outstanding Common Stock deemed beneficially owned by Samlyn, LP have been adjusted to account for: (i) the maximum amount of Warrants that the Samlyn Clients can collectively exercise, giving effect to the Blocker Provision; and (ii) the additional shares of Common Stock that would be issued by the issuer to the Samlyn Clients in connection with full exercise of the Warrants by the Samlyn Clients, giving effect to the Blocker Provision.

* Robert Pohly is deemed to beneficially own warrants of the issuer (“Warrants”) that are directly owned by certain of Samlyn Capital, LLC’s (“Samlyn Capital”) investment advisory clients (such clients, the “Samlyn Clients”). The Warrants, each of which converts into shares of Common Stock on a 1 to 1 basis, are subject to a blocker provision that prevents each Samlyn Client from exercising the Warrants if it or any of its affiliates, including Robert Pohly, would be more than a 9.99% beneficial owner of the issuer’s outstanding Common Stock following such exercise (the “Blocker Provision”). Accordingly, the number of shares of Common Stock and the percentage of the issuer’s outstanding Common Stock deemed beneficially owned by Robert Pohly have been adjusted to account for: (i) the maximum amount of Warrants that the Samlyn Clients can collectively exercise, giving effect to the Blocker Provision; and (ii) the additional shares of Common Stock that would be issued by the issuer to the Samlyn Clients in connection with full exercise of the Warrants by the Samlyn Clients, giving effect to the Blocker Provision.